Enbiosis AI Microbiome Test Now Available on Fullscript: Empowering Practitioners with Personalized Supplement Plans and Targeted Gut Microbiome Insights We are thrilled to announce that Enbiosis AI-powered microbiome analysis is now available on Fullscript’s powerful integrative care platform, which serves over 100,000 registered practitioners across the United States. This collaboration marks a pivotal step forward […]
Enbiosis AI-Powered Microbiome Analysis Now Available Through Evexia Diagnostics: Empowering Functional and Integrative Medicine Practitioners with Targeted Gut Microbiome Modulation We are excited to announce that Enbiosis Biotechnology has partnered with Evexia Diagnostics, making our AI-powered microbiome analysis accessible to thousands of Functional Medicine and Integrative Medicine practitioners across the United States. This collaboration marks […]
We are thrilled to unveil our latest achievement – the publication of our groundbreaking study titled ‘A Multicenter Randomized Controlled Trial Of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet Vs Low FODMAP Diet’ in the American Journal of Gastroenterology. As the leading clinical journal in gastroenterology and hepatology, it provides vital support for GI clinicians, validating our […]
We’re thrilled to announce that CNN has featured ENBIOSIS in an article highlighting our journey within the vibrant UK tech ecosystem. Founded in 2021, ENBIOSIS has been blazing a trail in revolutionizing AI-powered personalized gut health solutions. Since our triumphant win at the Tech Rocketship Awards, we’ve been pioneering innovative solutions in AI. Our Mision […]
Enbiosis Biotechnology has been shortlisted for the London regional UK StartUp Awards 2024! 🌟🏆 Our team is honored to be recognized in the category of Health & Wellbeing StartUp of the Year. StartUp Awards The UK StartUp Awards celebrate and champion the most promising start-ups across the United Kingdom, recognizing the bold individuals behind groundbreaking […]
Partnering with YourGutMap for Health Practitioner Support We’re happy to share that we’ve teamed up with YourGutMap to focus on the health practitioner channel. CEO Thomas Cookson and his team have a wealth of experience providing personalised nutrition tests with health practitioners all over the world. Revolutionizing Microbiome Testing with Enbiosis AI With the help […]
We are excited to announce a new partnership between ENBIOSIS and NUX LAB! This partnership will bring our AI-powered microbiome analysis services to patients in South America, starting with Panama, Chile, and Colombia, with the support of NUX LAB. ENBIOSIS Biotechnology employs cutting-edge technology to ensure precise and informative microbiome evaluations, paired with tailored health […]
Enbiosis thrilled to be joining the Association of British HealthTech Industries (ABHI) UK Pavilion at Arab Health 2024, which is taking place from 29 January – 1 February in Dubai. The exhibition – the largest event of its kind in the Middle East – brings together the healthcare world to network, share experience and do […]
We are excited to announce a new collaboration between our company and Saudi Innova Health Care, focusing on advancing microbiome-based health solutions in Saudi Arabia. Our aim is to enhance healthcare practices by offering personalized dietary and supplement suggestions, specifically designed to meet the distinct requirements of individual gut microbiomes, thereby promoting optimal health and […]
We’re Proud to Be Part of the UK Pavilion at the Leading Medical and Health Trade Fair We are excited to announce our participation in Medica 2023, the world’s premier trade fair for the medical and health sector, taking place from November 13th to 16th in Dusseldorf, Germany. This year, we are thrilled to be […]
العربية
Русский
Português
中文 (中国)
Türkçe
Spanish
Polski
Ελληνικά